Request Information


Media coverage of Auris Health

Contact us

J&J’s Auris Acquisition Featured in Forbes Article

Forbes recently featured Auris in an article about Johnson & Johnson's $3.5 billion all-cash acquisition of the company. In the deal, Auris is also eligible to receive up to $2.35 billion in additional milestone payments. This deal will boost J&J's plan to expand its robotics program.

Continue Reading

Auris Featured on MedCity News for Johnson & Johnson Acquisition

Auris was featured on MedCity News, an online publication covering the business of healthcare innovation, for its recent acquisition by Johnson & Johnson. Seeking to expand their digital surgery business, J&J paid $3.4 billion in cash to acquire Auris. Auris is also eligible to receive up to $2.3 billion in additional payments from J&J after hitting predetermined milestones. Auris will be included as part of Ethicon, J&J's medical device subsidiary.

Continue Reading

Auris Featured in Medium Article by Lux Co-Founder & Managing Partner

Peter Hébert, co-founder and Managing Partner of Lux, wrote an article about Auris that was published in Medium. Believing strongly in Auris's mission, Lux co-led Auris Health's Series A financing in 2012 and has invested nearly $50 million since the company's inception. On the heels of Auris's recent acquisition by Johnson & Johnson, Hébert's article highlights Auris's mission and how J&J will help to further that mission.

Continue Reading

J&J Purchase of Auris Featured in Xconomy

Johnson & Johnson's $3.4 billion all-cash purchase of Auris Health was featured in Xconomy, a publication that reports on the latest in business, life sciences, and technology.

Continue Reading

J&J Acquisition of Auris Featured on FierceBiotech

FierceBiotech featured Auris in an article about Johnson & Johnson's $3.4 billion all-cash agreement to acquire Auris Health. Auris could receive up to $2.35 billion in additional payments by hitting certain milestones. FierceBiotech previously named Auris among their "Fierce 15" in medtech in 2017.

Continue Reading

How Auris Health’s J&J Acquisition Could Impact Med-Tech Industry

Johnson & Johnson's deal to buy Auris Health Inc. could have major impact across the entire med-tech industry, according to the Wall Street Journal. At $3.4 billion, the cash deal is the largest acquisition of a venture-backed medical device company to date.

Continue Reading

TechCrunch Features Auris in Article About J&J Purchase

Auris was featured in an article on TechCrunch, an online publication that covers the tech industry, about the recent announcement that Johnson & Johnson will acquire Auris for $3.4 billion in cash.

Continue Reading

Monarch™ Platform Takes Center Stage at SXSW in Austin

Many come for the entertainment, others come for innovation. The Monarch™ Platform has been announced as a finalist for SXSW’s Interactive Innovation Award. Auris Health, creators of the first-of-its-kind technology, and Fjord, Accenture Interactive’s global design and innovation consultancy involved in the development of the system, are being honored for their joint innovation and efforts to revolutionize endoscopy.

Continue Reading

Auris Featured in Forbes Among Healthcare Startups Raising Venture Capital

According to Forbes, healthcare startups raised $28.8 billion in venture capital funding from January 2018 through November 2018. This is up 50% from last year over the same time frame, according to an analysis conducted for Forbes by Pitchbook.

Continue Reading

Auris Featured in BioWorld MedTech for Raising $220M in Funding

Auris was featured in an article in BioWorld MedTech, a news organization covering the medical technology industry. The article discusses how Auris recently raised $220 million in funding to back commercialization and development efforts for the Monarch Platform.

Continue Reading